Korean PDO Thread Lift: Why Threads Fade, and How to Build Support Instead

I have studied threads in the dissection room, under the microscope and in my own clinic for about a decade, and I have come to think the word "lifting" has misled our field. Most courses still teach the same three things: target the SMAS, pull back hard, and use more threads for a better lift. None of this is true. Threads fail when we pull against a living matrix. The answer is to build one.

Mechanical support and tissue response

The early support comes from the thread's mechanical engagement with tissue. Implantation also prompts a local tissue response, including fibrous tissue formation around the thread. The response develops while the material is changing; it is not a precise handover in which a permanent collagen support is guaranteed to replace the original thread.

Loss of barb shape, loss of tensile strength and complete PDO absorption are different endpoints. None, on its own, is the same as the end of a visible lifting effect. Thread design, the tissue environment and the treatment plan all matter. I explain these changes as a process, rather than giving a material-degradation date as a promise of how long a patient's result will last.

What the crisscross study showed

The question I wanted answered was simple: if the capsule carries the result, does the pattern of implantation change the capsule? We implanted fragments of a barbed PDO thread in mice, fan-shaped against crisscrossed, then sectioned and stained the tissue. Two findings. Capsule formation around the barbed segments was about three times that around the smooth segments of the same thread, so the barbs, not the filament, drive the fibrosis. And where the threads crossed, the fibrotic areas were about five times greater in width and density than in the fan pattern. Pattern, not quantity, produced the structure.

This is an animal model, Level of Evidence 4. It gives the biological rationale for crossing threads; it does not prove clinical superiority in the human face. I say that plainly because the pattern is mine.

Read the face before you mark it

The vector is decided before the marking pen touches the skin. Three things define it: where the tissue sits, where it should sit, and which fixed structure will hold it there. I choose the structure first and draw the vector back from it, and I mark against fixed landmarks, never on a cheek I am holding up by hand.

Then I test the tissue. How far does each area move under traction? With the patient briefly upside down you can see the natural, gravity-dependent shift of volume and the limit of the jawline contour. Threads will not lift soft tissue infinitely, and I use that test to show the patient, and to remind myself, what a realistic outcome is. Less mobile tissue usually calls for lower-face lifting and a malar highlight; mobile tissue allows real volume shifting. In Asian faces especially, be careful not to shift cheek volume onto an already prominent malar area.

Ageing shows first as descent of the superficial fat compartments, and each compartment moves on its own. So each descended compartment, typically the nasolabial and jowl fat, gets its own vector from its own entry point, rather than one fan of threads from a single entry.

Lift is not projection

Lift moves tissue up and out; projection moves it forward. Threads do the first well and the second only indirectly. In our cadaver work, more superficial placement gave more control of skin repositioning, while deeper placement gave a more projecting malar contour. When projection is the goal, I combine lifting threads with coiled threads placed into the cheek's retaining ligaments, where the coil re-tightens the ligament rather than adding volume like a filler.

The plane decides whether it lasts

For mid- and lower-face lifting vectors, I use the term Deep Subcutaneous Fat Layer just above SMAS. Here, “deep subcutaneous” means the deeper portion of the fat superficial to the SMAS, not the deep facial fat beneath it. This gives us an anatomical reference for discussing tissue engagement and depth; it is not one fixed millimetre setting across the face.

Too superficial a course can make a thread visible or create dimpling. Regional anatomy and the planned route also determine the risk to nerves and vessels. The temporal region, forehead and neck require separate anatomical planning around the temporal fasciae, galea and platysma. Simply naming a plane does not guarantee an injury-free passage or replace product-specific technique and regional assessment.

I read visual behaviour and tactile feedback together. A sharply outlined tip or marked skin drag can raise concern about shallow placement, but skin thickness and tissue condition affect what is visible. Conversely, the absence of a visible outline does not establish that the cannula is too deep.

Tactile feedback is an auxiliary check: I pay attention to tissue resistance and changes during passage across the planned route. A smooth passage or a brief “pop” does not, by itself, identify a named ligament or fat-compartment boundary, confirm the intended plane, or establish that nerves and vessels have been avoided. Unexpected resistance, pain or uncertainty about the route calls for stopping and reassessment, with imaging when needed, rather than pushing through or changing depth from a single cue.

In the lower-face approach described here, a subplatysmal passage is outside the intended working plane. Any decision to redirect follows reassessment of the anatomy and route.

Intentional intersections

Crossing threads changes what they build, not how much area they cover. Each thread is stabilised by the ones crossing it, so no single barbed segment carries the whole load. The capsules formed at the crossings merge into a mesh that resists descent in more than one direction, and the result does not fail when one thread loses grip. With the conventional fan pattern, my own patients had short-lived results, dimples and weeks of pain; that is what moved me to crossing.

Three rules keep it controlled. Cross in the same plane, because threads in different planes build two capsules that only overlap on a photograph. Cross where the tissue is dense. And control the number of crossings: packing barbed segments into one small volume of tissue is exactly how palpable threads and dimples happen.

The midface is where entry matters

A temple entry can lead into a midface route; the entry site alone does not identify the nerve branch at risk. Over the years I have seen referrals of synkinesis after repeated temple-entry threads, from adhesion of the orbicularis oculi and zygomaticus, and partial weakness (paresis) associated with scarring around the buccal branch. So I moved my midface entry to the lateral orbital rim, which allows a more vertical lift of the malar and nasolabial fat with fewer structures in the way. Near the eye, catching the orbicularis oculi at the entry can cause dimpling, eyelid pull or heaviness. Medially, the buccinator ligament is a useful anchor, but running deep there means crossing the fascia that protects the buccal branch of the facial nerve.

The temple and lateral forehead also involve a different motor risk: injury to the temporal, or frontal, branch of the facial nerve can weaken frontalis action and reduce brow elevation. Pitanguy's line is a surface reference for the approximate nerve course, not a guarantee of its depth or of a safe adjacent plane. This upper-face risk is distinct from the midface buccal-branch scarring account above.

When a thread lift goes wrong

Patients search for this, so let me be direct. In a 2026 meta-analysis of 26 studies, the most common problems were bruising, swelling and pain. Dimpling or asymmetry was reported in about 7%, thread exposure in about 5%, and infection in about 2%, with wide variation between studies. The wider consent list includes atypical mycobacterial infection, nerve injury, temporary stiffness, hair loss at entry points, pigment change, keloid, and thread extrusion, visibility or migration. Most are self-limiting; some need the thread removed. In the temple, a pass deeper than intended has caused a superficial temporal artery pseudoaneurysm.

What I tell my own patients is practical. A small dimple can appear when a barb catches during facial movement; pressing lightly just above it usually releases it, and they should call us. Pain with wide mouth opening is expected for a while. If they feel a fragment pushing toward the cheek skin or inside the mouth, they contact the clinic, because a thread under high tension can occasionally break and migrate. There are no wound-care visits, since nothing is cut, and I review at two weeks.

One more consequence is easy to forget. Threads can leave fibrous tracts that cross the planes a surgeon later dissects. In faces that have undergone repeated thread sessions, I have encountered thinner, scarred and less mobile SMAS, with remnant threads that can tear it. If a patient may want a facelift one day, I recommend a thread-free period of at least two years before surgery, and I explain this at the thread consultation. This is my clinical recommendation, not a universal waiting-period guideline or a guarantee that scarring has resolved. The operating surgeon still needs to assess the patient's treatment history and tissue condition.

When I would not recommend threads

Patient selection matters as much as the pattern. Very heavy soft tissue may not hold the intended repositioning, while very thin or atrophic tissue provides little cover and makes visibility, palpable threads and contour irregularity more concerning. Marked excess skin is another limit: threads reposition tissue; they do not excise it. In that situation, I discuss surgical assessment rather than promise a facelift result from threads.

I defer treatment when there is active infection or significant inflammation along the planned entry or thread route, including active acne, folliculitis or herpes lesions. Relevant dental infection also needs assessment before an elective implant procedure. A history of keloid or hypertrophic scarring, autoimmune or connective-tissue disease, poorly controlled diabetes and bleeding problems all require review and may lead me to decline or defer treatment. The selected device's instructions and the patient's disease activity, treatment and healing risk matter; these conditions do not all share one universal classification as absolute contraindications.

Anticoagulant or antiplatelet use needs a separate assessment of bleeding and thrombosis risk with the prescribing clinician. Patients should not stop prescribed medication themselves to qualify for threads.

I also defer treatment if a patient expects surgical-level correction, perfect symmetry or no bruising and swelling, and cannot accept the procedure's limits. Suspected body dysmorphic disorder calls for specialist assessment before proceeding. Sensitivity to a small irregularity alone does not establish that diagnosis.

Frequently asked questions

Dr. Song is a Global MINT Lift instructor for HansBiomed.

This article is educational material for medical professionals. It does not replace product labelling, local regulation or clinical judgement. Product names are mentioned for identification only.